Systemic, mucosal, and heterotypic immune induction in mice inoculated with Venezuelan equine encephalitis replicons expressing Norwalk virus-like particles

Journal of Virology

Volumn 76, Issue 2, 2002, Pages 730-742

  Harrington, P R ^a   Yount, B ^a   Johnston, R E ^a   Davis, N ^a   Moe, C ^a   Baric, R S ^a  

^a IL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CAPSID PROTEIN; VIRUS VACCINE;

ACUTE GASTROENTERITIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY RESPONSE; ARTICLE; CONTROLLED STUDY; ENCEPHALOMYELITIS; GENE MUTATION; HAMSTER; IMMUNE RESPONSE; MALE; MOUSE; MUCOSA; NONHUMAN; NORWALK GASTROENTERITIS VIRUS; PRIORITY JOURNAL; PROTEIN ASSEMBLY; REPLICON; VACCINATION; VIRUS CAPSID; VIRUS PARTICLE;

AMINO ACID SEQUENCE; ANIMALS; ANTIBODIES, VIRAL; CAPSID; CELL LINE; CLONING, MOLECULAR; CRICETINAE; CROSS REACTIONS; ENCEPHALITIS VIRUS, VENEZUELAN EQUINE; GENETIC VECTORS; HUMANS; IMMUNITY, MUCOSAL; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; INTESTINES; MICE; MOLECULAR SEQUENCE DATA; NOROVIRUS; REPLICON; VACCINATION; VIRAL VACCINES; VIRUS ASSEMBLY; VIRUS REPLICATION;

EID: 0036139183     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.76.2.730-742.2002     Document Type: Article

References (69)

1. Norwalk-like viral gastroenteritis outbreak in U.S. Army trainees
2. Recombinant Norwalk virus-like particles given orally to volunteers: Phase I study
3. Oral immunization with recombinant Norwalk virus-like particles induces a systemic and mucosal immune response in mice
4. Transmission of Norwalk virus during a football game
5. Mutations in the E2 glycoprotein of Venezuelan equine encephalitis virus confer heparan sulfate interaction, low morbidity, and rapid clearance from blood of mice
6. Nucleocapsid- and virus-like particles assemble in cells infected with recombinant baculoviruses or vaccinia viruses expressing the M and the S segments of Hantaan virus
7. Immunization with virus-like particles from cottontail rabbit papillomavirus (CRPV) can protect against experimental CRPV infection
8. Venezuelan equine encephalitis virus vectors expressing HIV-1 proteins: Vector design strategies for improved vaccine efficacy
9. Humoral, mucosal, and cellular immunity in response to a human immunodeficiency virus type 1 immunogen expressed by a Venezuelan equine encephalitis virus vaccine vector
10. Mucosal immunity induced by parenteral immunization with a live attenuated Venezuelan equine encephalitis virus vaccine candidate
11. Organization and expression of calicivirus genes
12. Virus-like particles as a rotavirus subunit vaccine
13. Heterotypic protection and induction of a broad heterotypic neutralization response by rotavirus-like particles
14. Attenuated mutants of Venezuelan equine encephalitis virus containing lethal mutations in the PE2 cleavage signal combined with a second-site suppressor mutation in E1
15. A viral vaccine vector that expresses foreign genes in lymph nodes and protects against mucosal challenge
16. Vaccination of macaques against pathogenic simian immunodeficiency virus with Venezuelan equine encephalitis virus replicon particles
17. Attenuating mutations in the E2 glycoprotein gene of Venezuelan equine encephalitis virus: Construction of single and multiple mutants in a full-length cDNA clone
18. Norwalk virus vaccines: Challenges and progress
19. Differences in the posttranslational modifications of human papillomavirus type 6b major capsid protein expressed from a baculovirus system compared with a vaccinia virus system
20. Molecular epidemiology of "Norwalk-like viruses" in outbreaks of gastroenteritis in the United States
21. Norwalk virus open reading frame 3 encodes a minor structural protein
22. The epidemiology of enteric caliciviruses from humans: A reassessment using new diagnostics
23. Molecular cloning and expression of major structural protein VP1 of the human polyomavirus JC virus: Formation of virus-like particles useful for immunological and therapeutic studies
24. Capsid protein diversity among Norwalk-like viruses
25. Comparison of the reactivities of baculovirus-expressed recombinant Norwalk virus capsid antigen with those of the native Norwalk virus antigen in serologic assays and some epidemiologic observations
26. Proteins of Norwalk virus
27. Recombinant norwalk virus-like particles administered intranasally to mice induce systemic and mucosal (fecal and vaginal) immune responses
28. Antigenic mapping of the recombinant Norwalk virus capsid protein using monoclonal antibodies
29. Specific proteolytic cleavage of recombinant Norwalk virus capsid protein
30. Improved mucosal protection against Venezuelan equine encephalitis virus is induced by the molecularly defined, live-attenuated V3526 vaccine candidate
31. Venezuelan equine encephalitis virus vaccines induce mucosal IgA responses and protection from airborne infection in BALB/c, but not C3H/HeN mice
32. Marburg virus vaccines based upon alphavirus replicons protect guinea pigs nonhuman primates
33. Altered phosphorylation pattern of simian virus 40 T antigen expressed in insect cells by using a baculovirus vector
34. T-cell mediated immunity
35. Heterotypic protection from rotavirus infection in mice vaccinated with virus-like particles
36. Expression, self-assembly, and antigenicity of the Norwalk virus capsid protein
37. Sequence and genomic organization of Norwalk virus
38. Multiple-challenge study of host susceptibility to Norwalk gastroenteritis in US adults
39. Alphaviruses
40. Norwalk group of viruses
41. Papillomavirus L1 major capsid protein self-assembles into virus-like particles that are highly immunogenic
42. Molecular epidemiology of human enteric caliciviruses in The Netherlands
43. Posttranslational side chain modification of a viral epitope results in diminished recognition by specific T cells
44. Expression of Norwalk virus capsid protein in transgenic tobacco and potato and its oral immunogenicity in mice
45. A new model system to study Norwalk virus immunity
46. Immunity to calicivirus infection
47. Food-related illness and death in the United States
48. Immunization with DNA, adenovirus or both in biodegradable alginate microspheres: Effect of route of inoculation on immune response
49. Human papillomavirus type 16 virus-like particles expressed in attenuated Salmonella typhimurium elicit mucosal and systemic neutralizing antibodies in mice
50. Vaccination strategies for mucosal immune responses
51. The effects of posttranslational side-chain modifications on the stimulatory activity, serum stability and conformation of synthetic peptides carrying T helper cell epitopes
52. Glycosylation of synthetic T helper cell epitopic peptides influences their antigenic potency and conformation in a sugar location-specific manner
53. Genomic diversity of "Norwalk like viruses" (NLVs): Pediatric infections in a Brazilian shantytown
54. X-ray crystallographic structure of the Norwalk virus capsid
55. Norwalk virus infection in Venezuela
56. Recombinant RNA replicons derived from attenuated Venezuelan equine encephalitis virus protect guinea pigs and mice from Ebola hemorrhagic fever virus
57. Replicon-helper systems from attenuated Venezuelan equine encephalitis virus: Expression of heterologous genes in vitro and immunization against heterologous pathogens in vivo
58. Synthesis and assembly of virus-like particles of human papillomaviruses type 6 and type 16 in fission yeast Schizosaccharomyces pombe
59. Papillomavirus-like particle vaccines for cervical cancer
60. Alphavirus vectors for gene expression and vaccines
61. Complete nucleotide sequence of the chiba virus genome and functional expression of the 3C-like protease in Escherichia coli
62. Human immune responses to a novel Norwalk virus vaccine delivered in transgenic potatoes
63. Structure of O-glycosidically linked oligosaccharides synthesized by the insect cell line Sf9
64. Alphavirus expression vectors and their use as recombinant vaccines: A minireview
65. Genetic polymorphism across regions of the three open reading frames of "Norwalk-like viruses"
66. Safety and immunogenicity of recombinant human immunodeficiency virus-like particles in rodents and rhesus macaques
67. Construction expression immunogenicity of chimeric HIV-1 virus-like particles
68. Biochemical characterization of a smaller form of recombinant Norwalk virus capsids assembled in insect cells